Avion Wealth’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
Other funds holding CHRS
TGY2IT
Avion Wealth's CHRS Position: Q3 2026 in Review
Avion Wealth sold out of Coherus Oncology (CHRS) in Q3 2026, closing a stake of 660 shares.
Avion Wealth first reported a position in CHRS in Q1 2025 and held it in 6 quarters. The position peaked at $1K in Q1 2026. 59 funds tracked by Wall St. Rank hold CHRS as of Q3 2026.
- Avion Wealth reported no remaining Coherus Oncology position as of Q3 2026 after selling out during the quarter.
- Avion Wealth sold 660 Coherus Oncology shares in Q3 2026.
- Avion Wealth first reported a position in Coherus Oncology in Q1 2025 and held it in 6 quarters.
- Avion Wealth's Coherus Oncology position peaked at $1K in Q1 2026.
- 59 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2026.
Based on Avion Wealth's 13F filing for Q3 2026, filed 4 Nov 2026.